Suppr超能文献

肝外门静脉阻塞患儿采用套扎术联合硬化疗法与单纯硬化疗法的比较

Band ligation plus sclerotherapy versus sclerotherapy alone in children with extrahepatic portal venous obstruction.

作者信息

Poddar Ujjal, Thapa Babu Ram, Singh Kartar

机构信息

Division of Pediatric Gastroenterology, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Clin Gastroenterol. 2005 Aug;39(7):626-9. doi: 10.1097/01.mcg.0000170765.36825.66.

Abstract

Although endoscopic band ligation (EVL) plus sclerotherapy (EST) has shown to be superior to any individual method, there is no study in children. We therefore analyzed our experience of EST and EVL + EST in children with extrahepatic portal venous obstruction (EHPVO). Over a period of 8 years, 136 children who presented with a history of recent variceal bleeding due to EHPVO were studied; 30 of them received EVL + EST and 106 received EST alone. In the EVL + EST group, after the first session of EVL, EST was done three times weekly until variceal eradication was achieved. The mean age of these children was 7 +/- 3.6 years with a male-to-female ratio of 2.6:1. The rate of eradication was comparable in both groups (100% in EVL + EST and 96% in EST). However, EVL + EST group required a significantly fewer sessions and lower volume of sclerosant (2 +/- 1 vs. 4.4 +/- 2 sessions, P < 0.001 and 3.1 +/- 2 mL versus 7.5 +/- 4 mL, P < 0.001 respectively). There were significantly less complications in EVL + EST group (10% vs. 36%, P < 0.01). Over a mean follow-up of 27 months, varices recurred in 6.6% and 10% cases, respectively. EVL + EST is a better method in the treatment of esophageal varices in children with EHPVO than EST alone, as it required fewer session and had fewer complication.

摘要

尽管内镜下套扎术(EVL)联合硬化疗法(EST)已被证明优于任何单一方法,但尚无针对儿童的研究。因此,我们分析了我们在肝外门静脉阻塞(EHPVO)患儿中应用EST以及EVL + EST的经验。在8年的时间里,对136例因EHPVO近期有静脉曲张出血病史的儿童进行了研究;其中30例接受了EVL + EST,106例仅接受了EST。在EVL + EST组,首次EVL术后,每周进行3次EST,直至静脉曲张消除。这些儿童的平均年龄为7±3.6岁,男女比例为2.6:1。两组的消除率相当(EVL + EST组为100%,EST组为96%)。然而,EVL + EST组所需的治疗次数明显较少,硬化剂用量也较低(分别为2±1次与4.4±2次,P < 0.001;3.1±2 mL与7.5±4 mL,P < 0.001)。EVL + EST组的并发症明显较少(10%对36%,P < 0.01)。平均随访27个月后,两组静脉曲张复发率分别为6.6%和10%。对于EHPVO患儿的食管静脉曲张治疗,EVL + EST比单独使用EST更好,因为它所需的治疗次数更少,并发症也更少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验